EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AI‐Assisted Drug Re‐Purposing for Human Liver Fibrosis

Yuan Guan, Lu Cui, Jakkapong Inchai, Zhuoqing Fang, Jacky Law, Alberto Alonzo Garcia Brito, Annalisa Pawlosky, Juraj Gottweis, Alexander Daryin, Artiom Myaskovsky, Lakshmi Ramakrishnan, Anil Palepu und 9 weitere

Advanced Science · 2025-11 · 12 (44)

DOI: 10.1002/advs.202508751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.09.2025. Verfasst von Yuan Guan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Pain and Perioperative Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA. Hauptthemen laut MEDLINE: Liver Cirrhosis, Artificial Intelligence, Drug Repositioning. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis has few treatment options due to the poor quality of the available animal and in vitro models. To address this, a hypothesis generating multi‐agent AI system (AI co‐scientist) is used to assist in re‐purposing drugs for treatment of liver fibrosis and direct their experimental characterization. The anti‐fibrotic efficacy and toxicity of 25 drugs are serially assessed in multi‐lineage human hepatic organoids grown in microwells (i.e., microHOs). Remarkably, three previously characterized anti‐fibrotic drugs and two AI co‐scientist‐recommended drugs that targeted epigenomic modifiers exhibited significant anti‐fibrotic activity and they promoted liver regeneration. Analysis of these five anti‐fibrotic drugs revealed that they all can reduce the generation of activated myofibroblasts and that each drug have unique effects on mesenchymal cells that generated their anti‐fibrotic effects. Since all five of the anti‐fibrotic drugs reduced TGFβ‐induced chromatin structural changes, epigenomic changes play an important role in the pathogenesis of liver fibrosis. One AI co‐scientist recommended drug is an FDA‐approved anti‐cancer treatment (Vorinostat) that reduced TGFβ‐induced chromatin structural changes by 91% and promoted liver parenchymal cell regeneration in microHOs. Hence, the integrated use of AI co‐scientist and this microHO platform identified a potential new generation of liver fibrosis treatments that also promote liver regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisArtificial IntelligenceDrug RepositioningHumansOrganoidsLiver

Stichwörter der Autor:innen

artificial Intelligencehepatic Organoidsliver fibrosis

Autor:innen und Institutionen

  • Department of Anesthesiology, Pain and Perioperative Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Department of Pathology, Stanford University School of Medicine, Stanford CA7Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.
  • Google Cloud, Zürich, 8050, Switzerland.
  • Arc Institute Palo Alto, Palo Alto, CA, 94304, USA.
  • Google Research, Mountain View, CA, 94043, USA.

ORCID-Profile: Gary Peltz

Förderung

  • NIDCD NIH HHS
  • NIH HHS

Zitieren

APA

Guan, Y., Cui, L., Inchai, J., Fang, Z., Law, J., Brito, A. A. G., Pawlosky, A., Gottweis, J., Daryin, A., Myaskovsky, A., Ramakrishnan, L., Palepu, A., Kulkarni, K., Weng, W. H., Cheng, Z., Natarajan, V., Karthikesalingam, A., Rong, K., Xu, Y., …, & Peltz, G. (2025). AI‐Assisted Drug Re‐Purposing for Human Liver Fibrosis. Advanced Science, 12(44). https://doi.org/10.1002/advs.202508751

Vancouver

Guan Y, Cui L, Inchai J, Fang Z, Law J, Brito AAG, et al. AI‐Assisted Drug Re‐Purposing for Human Liver Fibrosis. Advanced Science. 2025;12(44). doi:10.1002/advs.202508751

BibTeX
@article{Guan2025,
  author = {Guan, Yuan and Cui, Lu and Inchai, Jakkapong and Fang, Zhuoqing and Law, Jacky and Brito, Alberto Alonzo Garcia and Pawlosky, Annalisa and Gottweis, Juraj and Daryin, Alexander and Myaskovsky, Artiom and Ramakrishnan, Lakshmi and Palepu, Anil and Kulkarni, Kavita and Weng, Wei-Hung and Cheng, Zhuanfen and Natarajan, Vivek and Karthikesalingam, Alan and Rong, Keran and Xu, Yunhan and Tu, Tao and Peltz, Gary},
  title = {AI‐Assisted Drug Re‐Purposing for Human Liver Fibrosis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {44},
  doi = {10.1002/advs.202508751}
}
Kostenlos starten →